Euclid Advisors’s Hologic HOLX Stock Holding History

Euclid Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,350	Closed	-$185K	–	219
2016 Q2	$185K	Buy	+5,350	New	+$185K	0.01%	456

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Euclid Advisors's HOLX Position: Q3 2016 in Review

Euclid Advisors sold out of Hologic (HOLX) in Q3 2016, closing a stake of 5,350 shares — an estimated $185K sold.

Euclid Advisors first reported a position in HOLX in Q2 2016 and held it in 1 quarter. The position peaked at $185K in Q2 2016. 470 funds tracked by Wall St. Rank hold HOLX as of Q3 2016.

Euclid Advisors reported no remaining Hologic position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 5,350 Hologic shares in Q3 2016, an estimated $185K.
Euclid Advisors first reported a position in Hologic in Q2 2016 and held it in 1 quarter.
Euclid Advisors's Hologic position peaked at $185K in Q2 2016.
470 funds tracked by Wall St. Rank held Hologic as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.